SG11201405721VA - Method of producing a recombinant peptide - Google Patents

Method of producing a recombinant peptide

Info

Publication number
SG11201405721VA
SG11201405721VA SG11201405721VA SG11201405721VA SG11201405721VA SG 11201405721V A SG11201405721V A SG 11201405721VA SG 11201405721V A SG11201405721V A SG 11201405721VA SG 11201405721V A SG11201405721V A SG 11201405721VA SG 11201405721V A SG11201405721V A SG 11201405721VA
Authority
SG
Singapore
Prior art keywords
producing
recombinant peptide
recombinant
peptide
Prior art date
Application number
SG11201405721VA
Other languages
English (en)
Inventor
Stan Bastiras
Angelo Guidolin
Ben Hunt
Saif Raisheed
Reza Zareie
Original Assignee
Madeleine Pharmaceuticals Ρτy Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madeleine Pharmaceuticals Ρτy Ltd filed Critical Madeleine Pharmaceuticals Ρτy Ltd
Publication of SG11201405721VA publication Critical patent/SG11201405721VA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11201405721VA 2012-03-19 2013-03-19 Method of producing a recombinant peptide SG11201405721VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261612817P 2012-03-19 2012-03-19
PCT/AU2013/000273 WO2013138850A1 (en) 2012-03-19 2013-03-19 Method of producing a recombinant peptide

Publications (1)

Publication Number Publication Date
SG11201405721VA true SG11201405721VA (en) 2014-10-30

Family

ID=49221695

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201405721VA SG11201405721VA (en) 2012-03-19 2013-03-19 Method of producing a recombinant peptide

Country Status (8)

Country Link
US (1) US20150315259A1 (https=)
EP (1) EP2839010B1 (https=)
JP (1) JP2015510770A (https=)
KR (1) KR20140148420A (https=)
CN (2) CN107266554A (https=)
AU (2) AU2013234860B2 (https=)
SG (1) SG11201405721VA (https=)
WO (1) WO2013138850A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8947194B2 (en) 2009-05-26 2015-02-03 Solaredge Technologies Ltd. Theft detection and prevention in a power generation system
US20210330738A1 (en) * 2018-03-29 2021-10-28 Contrafect Corporation Antimicrobial, bacteriophage-derived polypeptides and their use against gram-negative bacteria
CN113121637B (zh) * 2020-01-15 2022-06-14 鲁南制药集团股份有限公司 一种重组蛋白的分离纯化方法
CN116981680A (zh) 2021-01-14 2023-10-31 生物催化剂有限责任公司 用于肽生产的组合物和方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691310A (en) * 1987-09-29 1997-11-25 Vesely; David L. Methods of treatment using proANF peptides
GB9716790D0 (en) * 1997-08-07 1997-10-15 Creative Peptides Sweden Ab Recombinant DNA molecules comprising multimeric copies of a gene sequence and expression thereof
DE69930938T2 (de) * 1998-07-10 2007-01-11 Scios Inc., Fremont Verfahren zur herstellung eines peptids mit einem pi grösser als 8 oder kleiner als 5
WO2000017336A1 (en) * 1998-09-19 2000-03-30 Sang Jun Lee Dna cassette encoding a multimer of a biologically active peptide and a cleavable linker attached thereto and process for preparing the biologically active peptide
US6759510B1 (en) * 2000-06-30 2004-07-06 Becton, Dickinson And Company Peptides for use in culture media
CN1363654A (zh) * 2001-07-19 2002-08-14 上海华谊生物技术有限公司 生产促胰岛素分泌肽glp－1(7－36)的基因工程菌以及生产glp－1(7－36)的方法
CA2485835C (en) * 2002-05-24 2018-03-06 Restoragen, Inc. Methods and dna constructs for high yield production of polypeptides
WO2004047871A2 (en) * 2002-11-26 2004-06-10 Nobex Corporation Modified naturetic compounds, conjugates, and uses thereof
AU2005227870A1 (en) * 2004-02-17 2005-10-13 University Of South Florida Materials and methods for treatment of inflammatory and cell proliferation disorders
DE602005004902T2 (de) * 2005-06-02 2008-10-16 Entelechon Gmbh Künstliches Protein, Verfahren für absolute Quantifizierung der Proteine und seine Benutzung
WO2009039982A2 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
RU2451750C2 (ru) * 2007-09-24 2012-05-27 Общество С Ограниченной Ответственностью "Герофарм" Способ получения рекомбинантного с-пептида проинсулина человека
US8527211B2 (en) * 2008-06-18 2013-09-03 Reza Zareie Method to produce recombinant MBP8298 and other polypeptides by nucleotide structure optimization
CN102575264A (zh) * 2009-09-18 2012-07-11 瑟莱克斯公司 增加的转基因表达和加工的产品和方法
US9018168B2 (en) * 2010-08-12 2015-04-28 Madeleine Pharmaceuticals Pty Ltd Therapeutic method for treating congestive heart failure
US20120277155A1 (en) * 2011-02-25 2012-11-01 Medtronic, Inc. Therapy for kidney disease and/or heart failure

Also Published As

Publication number Publication date
US20150315259A1 (en) 2015-11-05
EP2839010A4 (en) 2015-12-09
EP2839010B1 (en) 2018-04-25
JP2015510770A (ja) 2015-04-13
WO2013138850A1 (en) 2013-09-26
EP2839010A1 (en) 2015-02-25
AU2013234860A1 (en) 2014-10-16
AU2013234860B2 (en) 2016-01-21
CN104364378A (zh) 2015-02-18
CN107266554A (zh) 2017-10-20
AU2016100212A4 (en) 2016-04-14
KR20140148420A (ko) 2014-12-31

Similar Documents

Publication Publication Date Title
IL282393B (en) Production of heterodimeric proteins
SG11201504694VA (en) Method for producing a recombinant protein of interest
IL229247A0 (en) polypeptide
SG11201400432VA (en) Polypeptide vaccine
IL231604B (en) Therapeutic peptides
IL239737A0 (en) Method for protein production
ZA201401140B (en) Polypeptide separation methods
IL236324A0 (en) A method for the production of recombinant iduronate-2-sulfatase
SG11201501921SA (en) A method of purifying proteins
SG11201403814RA (en) Production of recombinant proteins with simple glycoforms
GB201111183D0 (en) Peptide
GB201215124D0 (en) A method of making a composite structure
GB201115910D0 (en) Peptides
LU92341B1 (en) Method of producing a shaped component
IL234753B (en) A method for preparing a recombinant peptide and the prepared peptide
EP2599787A4 (en) PROCESS FOR PEPTIDE MANUFACTURE
SG11201405721VA (en) Method of producing a recombinant peptide
EP2737065A4 (en) PROCESS FOR PRODUCING PROTEINS
EP2599786A4 (en) PROCESS FOR PEPTIDE MANUFACTURE
GB201223114D0 (en) Novel peptide
GB201101794D0 (en) Protein production
GB201112985D0 (en) Polypeptide
GB201112849D0 (en) Polypeptide
GB201106130D0 (en) Polypeptide
GB201115014D0 (en) Peptides